Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.

Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.2 appears in the page history, replacing Revision: v3.3.1 in the footer.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision v3.3.1 was added to the page history, replacing the previous revision v3.2.0.SummaryDifference0.0%

- Check26 days agoChange DetectedThe funding/operating status notice was removed from the Record History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedNew entries for Study Design, Study Status, and Recruitment Status were added, including a Completed status on 2025-10-28 (linked to the 2025-10-27 version). The previous 'Active, not recruiting' status was removed on 2025-07-14.SummaryDifference0.4%

- Check69 days agoChange DetectedUpdated operating status notice and bumped version to v3.2.0, replacing the previous v3.1.0 tag.SummaryDifference9%

- Check77 days agoChange DetectedThe page has updated the revision from v3.0.2 to v3.1.0, indicating a new release/version update.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.